Related Experiment Video
Updated: May 18, 2026
07:25
Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019
Hepatitis B virus: from immunobiology to immunotherapy
Daniel Grimm1, Maximilian Heeg, Robert Thimme
1Department of Medicine II, University of Freiburg, D-79106 Freiburg, Germany.
Clinical Science (London, England : 1979)
|September 28, 2012
Summary
Novel immunotherapies are needed for hepatitis B virus (HBV) infection due to current treatment limitations. This review explores HBV immunology and potential immune-stimulating strategies for effective viral control.
Area of Science:
- Immunology
- Virology
- Hepatology
Background:
- Current antiviral therapies for hepatitis B virus (HBV) infection have significant limitations.
- There is a critical need for novel therapeutic strategies to manage HBV infection.
- Understanding virus-host interactions is key to developing new treatments.
Purpose of the Study:
- To review the current state of HBV immunology.
- To identify potential targets for antiviral immunotherapy.
- To illustrate how immunotherapeutic interventions can control HBV infection.
Main Methods:
- Review of existing literature on HBV immunology.
- Analysis of virus-host interactions in acute and chronic HBV infection.
- Discussion of potential immunotherapeutic targets and strategies.
Main Results:
- Limitations of current antiviral therapies for HBV are highlighted.
- Several novel targets for antiviral immunotherapy have been identified.
- The potential of immune response stimulation for HBV resolution is discussed.
Conclusions:
- Immunotherapeutic interventions offer a promising approach to controlling HBV infection.
- Further research into HBV immunology can lead to effective novel therapies.
- Stimulating innate and adaptive immunity is a viable strategy for HBV treatment.
More Related Videos
10:37Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
Published on: October 20, 2021
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
Related Concept Videos
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:28Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:26Human Virome
The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible only with...